Fresh perspectives on clinical terminologies, code mapping, and patient insights from the experts at IMO.
In part two of our four-part blog series about COVID-19 variants, we explained the importance of data harmonization, which must occur before sequencing, clinical, and epidemiologic data can be combined. In part three, we look at how to maintain the link between patients and their sequence.
Back in May, IMO’s Chief Clinical Officer, Steven Rube, MD, FAMIA, sat down with HIMSS to talk about how the COVID-19 pandemic has highlighted key areas in clinical documentation where the process of recording patient information is not intuitive – and why having greater specificity in clinical notes is critical to making the most of the patient record.
With over 25 years of clinical terminology curation and governance, IMO is one of health IT’s best kept secrets – but not for much longer. Highlighting just a few of the secondary uses enabled by IMO’s comprehensive terminology is Chief Strategy Officer, Dale Sanders.
As the COVID-19 pandemic continues to impact daily life, addressing interoperability in healthcare is critically important. So, we pored over the most recent legislation on the topic – the 21st Century Cures Act – and learned about the new responsibilities payers have in healthcare interoperability. Read a snippet of our summary below.
Part one of our blog series about SARS-CoV-2 variants explained the value of combining viral sequencing data with epidemiological and clinical information in the fight against the pandemic. But challenges remain. To be useable, data must be understandable for all users – a process that’s not as straightforward as it seems.
The fact that the letters IMO don’t just stand for Intelligent Medical Objects isn’t lost on this healthcare data enablement company. Indeed, we believe it’s high time IMO embraced our text-slang status and we’re doing just that with In My Opinion, an Ideas series featuring Q&As with IMO employees. The software engineering department’s summer intern, Giselle Martinez, takes the August spotlight.
As concern around the delta variant – among other mutations – of the SARS-CoV-2 virus grows, it’s critical that we take advantage of all the resources at our disposal to help combat the pandemic. A key tool in our toolbox? Harnessing the power of genomic sequencing. In part one of this four-part blog series, we’re explaining the value of sequencing with respect to emerging variants.
August is National Wellness Month – the perfect time to tap into the wisdom and expertise of IMO’s Chief Medical Officer, Andrew S. Kanter, MD. Below, he shares advice and insights on his mindfulness practice, the sessions he leads at IMO, and how mindfulness aligns with the company’s culture and priorities.
Posted originally on LinkedIn, IMO’s new Chief Strategy Officer Dale Sanders shares his thoughts on why he joined IMO and the unique role the company is poised to play improving data quality in healthcare.
IMO’s new offering – the IMO Core cSmart app – is an exciting collaboration designed to support clinical documentation and other needs of Cerner® EHR users.
Capturing social determinants of health (SDOH) enables the use of data to fight healthcare disparities that often result from inequity. Read on for an introduction to what SDOH are and how the data may be used.
While the pandemic continues, the 2020 Tokyo Olympics have provided a welcome spectacle to many worldwide – allowing us to embrace our global community, celebrate new world records, and of course, champion some ICD-10-CM codes.
